Cargando…
Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT)
AIMS/HYPOTHESIS: Our aim was to evaluate the safety and efficacy of a planned therapeutic withdrawal of all antihypertensive and diuretic medications, on commencing a formula low-energy diet replacement, targeting remission of type 2 diabetes. METHODS: Post hoc analysis of changes in BP, antihyperte...
Autores principales: | Leslie, Wilma S., Ali, Eman, Harris, Leanne, Messow, C. Martina, Brosnahan, Naomi T., Thom, George, McCombie, E. Louise, Barnes, Alison C., Sattar, Naveed, Taylor, Roy, Lean, Michael E. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382659/ https://www.ncbi.nlm.nih.gov/pubmed/34056684 http://dx.doi.org/10.1007/s00125-021-05471-x |
Ejemplares similares
-
Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT)
por: Cassidy, Sophie, et al.
Publicado: (2022) -
The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial
por: Leslie, Wilma S., et al.
Publicado: (2016) -
Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort
por: Taylor, Roy, et al.
Publicado: (2017) -
Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme
por: Xin, Yiqiao, et al.
Publicado: (2020) -
Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby)
por: Sattar, Naveed, et al.
Publicado: (2022)